GLTO Galecto Inc
Price (delayed)
$3.23
Market cap
$4.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$18.53
Enterprise value
-$9.84M
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Highlights
The quick ratio has soared by 108% YoY and by 47% from the previous quarter
GLTO's EPS is up by 49% year-on-year and by 3.9% since the previous quarter
GLTO's equity has dropped by 51% year-on-year and by 24% since the previous quarter
Key stats
What are the main financial stats of GLTO
Market
Valuations
Earnings
Shares outstanding
1.32M
Market cap
$4.27M
Enterprise value
-$9.84M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.27
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$22.26M
Net income
-$21.44M
EBIT
-$21.4M
EBITDA
-$21.22M
Free cash flow
-$18.62M
Per share
Balance sheet
Liquidity
EPS
-$18.53
EPS diluted
-$18.53
Free cash flow per share
-$16.09
Book value per share
$12.02
Revenue per share
$0
TBVPS
$14.81
Total assets
$17.13M
Total liabilities
$1.3M
Debt
$61,000
Equity
$15.83M
Working capital
$15.64M
Debt to equity
0
Current ratio
14.07
Quick ratio
11.84
Net debt/EBITDA
0.67
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-85.5%
Return on equity
-96.9%
Return on invested capital
-787.3%
Return on capital employed
-134.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GLTO stock price
How has the Galecto stock price performed over time
Intraday
14.54%
1 week
-18.02%
1 month
-26.26%
1 year
-83.12%
YTD
-30.54%
QTD
4.19%
Financial performance
How have Galecto's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.26M
Net income
-$21.44M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 44% YoY
GLTO's net income is up by 44% year-on-year
Growth
What is Galecto's growth rate over time
Valuation
What is Galecto stock price valuation
P/E
N/A
P/B
0.27
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLTO's EPS is up by 49% year-on-year and by 3.9% since the previous quarter
GLTO's price to book (P/B) is 71% less than its 5-year quarterly average of 0.8 and 62% less than its last 4 quarters average of 0.6
GLTO's equity has dropped by 51% year-on-year and by 24% since the previous quarter
Efficiency
How efficient is Galecto business performance
The company's return on invested capital has shrunk by 87% QoQ
The return on assets has declined by 22% since the previous quarter and by 18% year-on-year
Galecto's ROE has decreased by 20% from the previous quarter and by 3.4% YoY
Dividends
What is GLTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GLTO.
Financial health
How did Galecto financials performed over time
The current ratio has soared by 123% YoY and by 62% QoQ
The quick ratio has soared by 108% YoY and by 47% from the previous quarter
Galecto's debt is 100% less than its equity
GLTO's equity has dropped by 51% year-on-year and by 24% since the previous quarter
Galecto's debt has decreased by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.